Literature DB >> 23487264

Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.

Jie Ding1, Shenglin Huang, Ying Wang, Qi Tian, Ruopeng Zha, Haibing Shi, Qifeng Wang, Chao Ge, Taoyang Chen, Yingjun Zhao, Linhui Liang, Jinjun Li, Xianghuo He.   

Abstract

UNLABELLED: Nuclear factor kappa B (NF-κB) is an important factor linking inflammation and tumorigenesis. In this study we experimentally demonstrated through a high-throughput luciferase reporter screen that NF-κB signaling can be directly targeted by nearly 29 microRNAs (miRNAs). Many of these miRNAs can directly target NF-κB signaling nodes by binding to their 3' untranslated region (UTR). miR-195, a member of the miR-15 family, is frequently down-regulated in gastrointestinal cancers, especially in hepatocellular carcinoma (HCC). The expression level of miR-195 is inversely correlated with HCC tumor size. We further show that miR-195 suppresses cancer cell proliferation and migration in vitro and reduces tumorigenicity and metastasis in vivo. Additionally, miR-195 may exert its tumor suppressive function by decreasing the expression of multiple NF-κB downstream effectors by way of the direct targeting of IKKα and TAB3.
CONCLUSION: Multiple miRNAs are involved in the NF-κB signaling pathway and miR-195 plays important inhibitory roles in cancer progression and may be a potential therapeutic target.
Copyright © 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23487264     DOI: 10.1002/hep.26378

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  62 in total

Review 1.  The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

Authors:  Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Motoko Ohno; Akemi Takata; Chikako Shibata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-11-21       Impact factor: 7.527

2.  miR-958 inhibits Toll signaling and Drosomycin expression via direct targeting of Toll and Dif in Drosophila melanogaster.

Authors:  Shengjie Li; Yao Li; Li Shen; Ping Jin; Liming Chen; Fei Ma
Journal:  Am J Physiol Cell Physiol       Date:  2016-12-14       Impact factor: 4.249

3.  Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.

Authors:  Ling Li; Klaus Piontek; Masaharu Ishida; Michel Fausther; Jonathan A Dranoff; Rongdang Fu; Esteban Mezey; Stephen J Gould; Francis K Fordjour; Stephen J Meltzer; Alphonse E Sirica; Florin M Selaru
Journal:  Hepatology       Date:  2016-08-29       Impact factor: 17.425

4.  Protein complex scaffolding predicted as a prevalent function of long non-coding RNAs.

Authors:  Diogo M Ribeiro; Andreas Zanzoni; Andrea Cipriano; Riccardo Delli Ponti; Lionel Spinelli; Monica Ballarino; Irene Bozzoni; Gian Gaetano Tartaglia; Christine Brun
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

5.  miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.

Authors:  Wenjing Mu; Chaobo Hu; Haibin Zhang; Zengqiang Qu; Jin Cen; Zhixin Qiu; Chao Li; Haozhen Ren; Yixue Li; Xianghuo He; Xiaolei Shi; Lijian Hui
Journal:  Cell Res       Date:  2015-02-20       Impact factor: 25.617

6.  Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Authors:  Yan Du; Xue Han; Rui Pu; Jiaxin Xie; Yuwei Zhang; Guangwen Cao
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

7.  LINC00473 antagonizes the tumour suppressor miR-195 to mediate the pathogenesis of Wilms tumour via IKKα.

Authors:  Shibo Zhu; Wen Fu; Liyu Zhang; Kai Fu; Jinhua Hu; Wei Jia; Guochang Liu
Journal:  Cell Prolif       Date:  2017-11-20       Impact factor: 6.831

Review 8.  Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship.

Authors:  Denada Dibra; Lopa Mishra; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-05-09

Review 9.  NAFLD, NASH and liver cancer.

Authors:  Gregory A Michelotti; Mariana V Machado; Anna Mae Diehl
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-01       Impact factor: 46.802

Review 10.  Macro advances in microRNAs and myocardial regeneration.

Authors:  Jun Wang; James F Martin
Journal:  Curr Opin Cardiol       Date:  2014-05       Impact factor: 2.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.